204 related articles for article (PubMed ID: 25205672)
21. [The value of extended surgery for pancreatic cancer in the context of neoadjuvant therapy].
Zhang TP; Liu YZ; Cao Z
Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):481-485. PubMed ID: 32610414
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
Pisters PW; Evans DB
Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
[No Abstract] [Full Text] [Related]
23. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
White RR; Tyler DS
Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
[TBL] [Abstract][Full Text] [Related]
24. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
25. The Virginia Mason approach to localized pancreatic cancer.
Picozzi VJ; Traverso LW
Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940
[TBL] [Abstract][Full Text] [Related]
26. Role of surgery in pancreatic cancer.
Buanes TA
World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216
[TBL] [Abstract][Full Text] [Related]
27. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer.
Furuse J; Shibahara J; Sugiyama M
J Hepatobiliary Pancreat Sci; 2018 May; 25(5):261-268. PubMed ID: 29651809
[TBL] [Abstract][Full Text] [Related]
28. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.
Abbott DE; Tzeng CW; Merkow RP; Cantor SB; Chang GJ; Katz MH; Bentrem DJ; Bilimoria KY; Crane CH; Varadhachary GR; Abbruzzese JL; Wolff RA; Lee JE; Evans DB; Fleming JB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S500-8. PubMed ID: 23397153
[TBL] [Abstract][Full Text] [Related]
29. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer.
Lutz MP; Zalcberg JR; Ducreux M; Aust D; Bruno MJ; Büchler MW; Delpero JR; Gloor B; Glynne-Jones R; Hartwig W; Huguet F; Laurent-Puig P; Lordick F; Maisonneuve P; Mayerle J; Martignoni M; Neoptolemos J; Rhim AD; Schmied BM; Seufferlein T; Werner J; van Laethem JL; Otto F
Eur J Cancer; 2017 Jul; 79():41-49. PubMed ID: 28460245
[TBL] [Abstract][Full Text] [Related]
30. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic cancer: current and future treatment strategies.
Pliarchopoulou K; Pectasides D
Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
[TBL] [Abstract][Full Text] [Related]
32. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
Christians KK; Heimler JW; George B; Ritch PS; Erickson BA; Johnston F; Tolat PP; Foley WD; Evans DB; Tsai S
Surgery; 2016 Mar; 159(3):893-900. PubMed ID: 26602840
[TBL] [Abstract][Full Text] [Related]
33. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Satoi S; Yamaue H; Kato K; Takahashi S; Hirono S; Takeda S; Eguchi H; Sho M; Wada K; Shinchi H; Kwon AH; Hirano S; Kinoshita T; Nakao A; Nagano H; Nakajima Y; Sano K; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):590-600. PubMed ID: 23660962
[TBL] [Abstract][Full Text] [Related]
34. Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy.
Evans DB; George B; Tsai S
Ann Surg Oncol; 2015 Oct; 22(11):3409-13. PubMed ID: 26122369
[No Abstract] [Full Text] [Related]
35. Cancer of the pancreas.
Andre T; Hammel P; Lacaine F; Palazzo L; Becouarn Y; Mornex F
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S75-2S80. PubMed ID: 17151566
[No Abstract] [Full Text] [Related]
36. [Pancreatic cancer - current effective diagnostic and therapeutic approach].
Ryska M
Cas Lek Cesk; 2016; 155(1):38-43. PubMed ID: 26898790
[TBL] [Abstract][Full Text] [Related]
37. New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.
Berardi R; Verdecchia L; Scartozzi M; Cascinu S
JOP; 2005 Jan; 6(1 Suppl):118-21. PubMed ID: 15650296
[No Abstract] [Full Text] [Related]
38. Surgical approach to pancreatic exocrine neoplasms.
Wargo JA; Warshaw AL
Minerva Chir; 2005 Dec; 60(6):445-68. PubMed ID: 16401999
[TBL] [Abstract][Full Text] [Related]
39. Combined-modality treatment for operable pancreatic adenocarcinoma.
Pisters PW; Wolff RA; Crane CH; Evans DB
Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
[TBL] [Abstract][Full Text] [Related]
40. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings.
Badiyan SN; Molitoris JK; Chuong MD; Regine WF; Kaiser A
Surg Oncol Clin N Am; 2017 Jul; 26(3):431-453. PubMed ID: 28576181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
